Actively Recruiting
AI-based Measurements of Tumour Burden in PSMA PET-CT
Led by Elin Tragardh · Updated on 2026-04-28
1500
Participants Needed
2
Research Sites
465 weeks
Total Duration
On this page
Sponsors
E
Elin Tragardh
Lead Sponsor
L
Lund University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary aim of the present study is to evaluate how automatically calculated (by an AI-based method) tumour burden, measured as tumour volume (TV) and as tumour uptake (TU: TV x SUVmean) in the prostate/prostate bed, pelvic lymph nodes, distant lymph nodes, bone and as the total tumour burden predicts overall survival (OS) in patients with prostate cancer (newly diagnosed and patients with biochemical recurrence).
CONDITIONS
Official Title
AI-based Measurements of Tumour Burden in PSMA PET-CT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients referred to a clinically indicated 18F-PSMA-1007 PET-CT scan at Sk�e5ne University Hospital, Lund or Malm�f6, Sweden
You will not qualify if you...
- Patients under 20 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Skåne University Hospital
Lund, Sweden
Actively Recruiting
2
Skåne university hospital
Malmö, Sweden
Actively Recruiting
Research Team
E
Elin Tragardh, Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here